30 Jan 2024 • In reassuring findings, antenatal exposure to low-dose aspirin (81 mg) was not associated with altered neurodevelopmental outcomes at age 3.

• The Bayley-III cognitive composite score demonstrated noninferiority & no significant differences were observed in language and motor composite scores.
• Various aspects of the Ages & Stages Questionnaire, along with maternal delivery outcomes, showed no significant variations.
• Similarly, the communication, gross motor, fine motor, problem-solving, and personal–social components of the ASQ-3 did not differ between groups.

Source: Obstetrics & Gynacology | Read full story